HUMAN MONOCLONAL ANTIBODY TO GANGLIOSIDE GM2 FOR MELANOMA TREATMENT
Authors:
- ReikoF. IrieRIReikoF. Irie
- Takasumi MatsukiTMTakasumi Matsuki
- DonaldL. MortonDMDonaldL. Morton
- 1 April 1989
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 333 (8641) , 786-787
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Gangliosides of Human Melanoma2JNCI: Journal of the National Cancer Institute, 1987
- Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.Proceedings of the National Academy of Sciences, 1986
- Gangliosides of normal and neoplastic human melanocytesBiochemical and Biophysical Research Communications, 1984
- Ganglioside GM2 as a human tumor antigen (OFA-I-1).Proceedings of the National Academy of Sciences, 1983